OrbiMed Capital GP VII LLC - Insider Non-Derivative Transactions at Enliven Therapeutics, Inc. (ELVN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 16, 2024, OrbiMed Capital GP VII LLC's relationship to Enliven Therapeutics, Inc. (ELVN) is Director,TenPercentOwner, and currently has 7,663,349 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ELVN insiders.
Data Source: SEC.
OrbiMed Capital GP VII LLC - Insider Non-Derivative Transactions of ELVN Common Stock
OrbiMed Capital GP VII LLC - Insider Non-Derivative Transactions at ELVN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 17, 2024 | Sell -- (Common Stock) | 33300 | 22.14 | 254814 |
| May 17, 2024 | Sell -- (Common Stock) | 1000000 | 22.14 | 7663349 |
| May 18, 2023 | M -- (Common Stock) | 2125 | 4.28 | 8663349 |